Caeneus to run the rule on lithium play

Published 26-APR-2016 12:23 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Lithium hopeful Caeneus Minerals (ASX:CAD) will begin exploration work at the Lida Valley brine project in Nevada as it attempts to prove up a resource in Tesla’s backyard.

The ASX-listed company told its shareholders earlier today that it would kick off exploration in May, starting with a ground gravity program.

The CAD board will visit the area in the second week in May, as it figures out whether or not to take an option on the project.

At this stage, it is thought the project covers a sedimentary basin similar to that in existence at the Clayton Valley – which contains at least five lithium-bearing aquifers.

The gravity program should help define the limits of the basin, and identify any significant structures at the project. These structures often host lithium-bearing fluids.

The information gleamed from the program will be supplied to shareholders ahead of a vote on the acquisition of the Lida Valley project.

After shareholder approval, drilling will begin, with drillholes pencilled in to be less than 300m in depth.

More on Caeneus (ASX:CAD)

CAD is currently running the rule over two projects in Nevada thought to be rich in lithium-bearing brines, the Lida Valley and Muddy Mountains projects.

An overview of Caeneus Minerals' lithium plays

An overview of Caeneus Minerals’ lithium plays

CAD is attempting to cash in on the buzz currently being generated by lithium’s role in the lithium-ion battery revolution which is in part being driven by Tesla’s electric cars.

Tesla currently has a so-called ‘gigafactory’ in Nevada, and has previously stated its preference to source materials from North America.

Muddy Mountain is a potential high impact ‘district-scale’ lithium clay project, with strongly anomalous lithium up to 1000 parts per million lithium previously hit as part of historical drilling.

The Lida Valley Project is a significant regional Intermontane Basin with a drainage area of approximately 150km2.

It is considered by CAD to be an ideal location for the development of lithium rich brine deposits.

tags

LITHIUM


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X